Skip to main content
SpringerLink
Log in

Cutaneous T-cell Lymphomas

  • Chapter
  • First Online:
Neoplastic Hematopathology

Part of the book series: Contemporary Hematology ((CH))

Abstract/Scope of Chapter

T-cell malignancies presenting in the skin include mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and the related regressing lesion lymphomatoid papulosis as well as viral-associated adult T-cell leukemia/lymphoma. Rarer and more aggressive primary cutaneous lymphomas include extranodal natural killer cell/T-cell lymphoma, nasal type, subcutaneous panniculitits-like T-cell lymphoma, cutaneous gamma-delta T-cell lymphoma, and cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Systemic T-cell lymphomas that frequently involve the skin secondarily, such as angioimmunoblastic T-cell lymphoma, systemic anaplastic large cell lymphoma, and peripheral T-cell lymphoma, unspecified, are covered in Chap. 22.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Willemze R, Meijer CJ. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol 2006;33(Suppl. 1):18-26.

    Article  PubMed  Google Scholar 

  2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85.

    Article  PubMed  CAS  Google Scholar 

  3. Kinney MC, Jones D. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. Am J Clin Pathol 2007;127:670-86.

    Article  PubMed  Google Scholar 

  4. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumour of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.

    Google Scholar 

  5. LeBoit PE. Pathology and genetics of skin tumors. Lyon, France: IARC Press, 2006.

    Google Scholar 

  6. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis Fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857-66.

    Article  PubMed  Google Scholar 

  7. Zackheim H, Amin S, Kashani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999;40:418-25.

    Article  PubMed  CAS  Google Scholar 

  8. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007;143:854-9.

    Article  PubMed  Google Scholar 

  9. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994;18:645-67.

    Article  PubMed  CAS  Google Scholar 

  10. Lu D, Duvic M, Medeiros LJ, Luthra R, Dorfman DM, Jones D. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol 2001;115:413-21.

    Article  PubMed  CAS  Google Scholar 

  11. Ralfkiaer E. Controversies and discussion on early diagnosis of cutaneous T-cell lymphoma. Phenotyping. Dermatol Clin 1994;12:329-34.

    PubMed  CAS  Google Scholar 

  12. Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res 2004;10:5587-94.

    Article  PubMed  CAS  Google Scholar 

  13. Lu D, Patel KA, Duvic M, Jones D. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 2002;29:465-72.

    Article  PubMed  Google Scholar 

  14. Jones D, Dang NH, Duvic M, Washington LT, Huh YO. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885-92.

    Article  PubMed  CAS  Google Scholar 

  15. Washington LT, Huh YO, Powers LC, Duvic M, Jones D. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2002;2:5.

    Article  PubMed  Google Scholar 

  16. Vega F, Luthra R, Medeiros LJ, et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 2002;100:3369-73.

    Article  PubMed  CAS  Google Scholar 

  17. van Doorn R, Van Haselen CW, van Voorst Vader PC, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000;136:504-10.

    Article  PubMed  Google Scholar 

  18. Vermeer MH, Geelen FA, Kummer JA, Meijer CJ, Willemze R. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol 1999;154:1203-10.

    Article  PubMed  CAS  Google Scholar 

  19. Jones D, O’Hara C, Kraus MD, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000;96:685-90.

    PubMed  CAS  Google Scholar 

  20. van Doorn R, van Kester MS, Dijkman R, et al. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 2009;113:127-36.

    Article  PubMed  Google Scholar 

  21. Smoller BR, Santucci M, Wood GS, Whittaker SJ. Histopathology and genetics of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 2003;17:1277-311.

    Article  PubMed  Google Scholar 

  22. Kari L, Loboda A, Nebozhyn M, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003;197:1477-88.

    Article  PubMed  CAS  Google Scholar 

  23. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 2003;101:1513-9.

    Article  PubMed  CAS  Google Scholar 

  24. Mao X, Orchard G, Vonderheid EC, et al. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J Invest Dermatol 2006;126:1388-95.

    Article  PubMed  CAS  Google Scholar 

  25. Navas IC, Algara P, Mateo M, et al. p16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides. Lab Invest 2002;82:123-32.

    PubMed  CAS  Google Scholar 

  26. Zhang C, Toulev A, Kamarashev J, Qin JZ, Dummer R, Dobbeling U. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sezary syndrome and role of the bmi-1 and ras oncogenes in disease progression. Hum Pathol 2007;38:995-1002.

    Article  PubMed  CAS  Google Scholar 

  27. Klemke CD, Dippel E, Assaf C, et al. Follicular mycosis fungoides. Br J Dermatol 1999;141:137-40.

    Article  PubMed  CAS  Google Scholar 

  28. Cerroni L, Fink-Puches R, El-Shabrawi-Caelen L, Soyer HP, LeBoit PE, Kerl H. Solitary skin lesions with histopathologic features of early mycosis fungoides. Am J Dermatopathol 1999;21:518-24.

    Article  PubMed  CAS  Google Scholar 

  29. Kempf W, Ostheeren-Michaelis S, Paulli M, et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol 2008;144:1609-17.

    Article  PubMed  Google Scholar 

  30. Diwan AH, Prieto VG, Herling M, Duvic M, Jones D. Primary Sezary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol 2005;123:510-5.

    Article  PubMed  Google Scholar 

  31. Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood 1997;89:32-40.

    PubMed  CAS  Google Scholar 

  32. Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome. Br J Dermatol 2008;159:105-12.

    Article  PubMed  CAS  Google Scholar 

  33. Sarris AH, Esgleyes-Ribot T, Crow M, et al. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood 1995;86:651-8.

    PubMed  CAS  Google Scholar 

  34. Tensen CP, Vermeer MH, van der Stoop PM, et al. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 1998;111:222-6.

    Article  PubMed  CAS  Google Scholar 

  35. Wu J, Nihal M, Siddiqui J, Vonderheid EC, Wood GS. Low FAS/CD95 Expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. J Invest Dermatol 1009;129:1165-73.

    Google Scholar 

  36. Yagi H, Seo N, Ohshima A, et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 2006;30:1111-9.

    Article  PubMed  Google Scholar 

  37. Talpur R, Jones DM, Alencar AJ, et al. CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma. J Invest Dermatol 2006;126:575-83.

    Article  PubMed  CAS  Google Scholar 

  38. Hahtola S, Tuomela S, Elo L, et al. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma. Clin Cancer Res 2006;12:4812-21.

    Article  PubMed  CAS  Google Scholar 

  39. Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol 1999;6:79-84.

    PubMed  CAS  Google Scholar 

  40. Papadavid E, Economidou J, Psarra A, et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome. Br J Dermatol 2003;148:709-18.

    Article  PubMed  CAS  Google Scholar 

  41. Feldman AL, Law M, Remstein ED, et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009;23:574-80.

    Google Scholar 

  42. Mori M, Manuelli C, Pimpinelli N, et al. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression. Blood 1999;94:3077-83.

    PubMed  CAS  Google Scholar 

  43. Goteri G, Simonetti O, Rupoli S, et al. Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study. Br J Dermatol 2007;157:41-8.

    Article  PubMed  CAS  Google Scholar 

  44. Gjerdrum LM, Woetmann A, Odum N, et al. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations. Eur J Haematol 2008;80:483-9.

    Article  PubMed  CAS  Google Scholar 

  45. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428-37.

    Article  PubMed  CAS  Google Scholar 

  46. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-13.

    PubMed  CAS  Google Scholar 

  47. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997;133:1081-6.

    Article  PubMed  CAS  Google Scholar 

  48. Sen F, Rassidakis GZ, Jones D, Medeiros LJ. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. Mod Pathol 2002;15:625-31.

    Article  PubMed  Google Scholar 

  49. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 2003;101:3407-12.

    Article  PubMed  CAS  Google Scholar 

  50. Jones D, Vega F, Sarris AH, Medeiros LJ. CD4-CD8-"Double-negative" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol 2002;26:225-31.

    Article  PubMed  Google Scholar 

  51. Valbuena JR, Herling M, Admirand JH, Padula A, Jones D, Medeiros LJ. T-cell prolymphocytic leukemia involving extramedullary sites. Am J Clin Pathol 2005;123:456-64.

    Article  PubMed  Google Scholar 

  52. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713-22.

    Article  PubMed  CAS  Google Scholar 

  53. Scheffer E, Meijer CJ, Van Vloten WA. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer 1980;45:137-48.

    Article  PubMed  CAS  Google Scholar 

  54. Sausville EA, Worsham GF, Matthews MJ, et al. Histologic assessment of lymph nodes in mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol 1985;16:1098-109.

    Article  PubMed  CAS  Google Scholar 

  55. Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002;118:949-56.

    Article  PubMed  CAS  Google Scholar 

  56. Karenko L, Hahtola S, Paivinen S, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 2005;65:8101-10.

    Article  PubMed  CAS  Google Scholar 

  57. Nagasawa T, Takakuwa T, Takayama H, et al. Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions. Oncology 2004;67:130-4.

    Article  PubMed  CAS  Google Scholar 

  58. Scarisbrick JJ, Woolford AJ, Calonje E, et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sezary syndrome. J Invest Dermatol 2002;118:493-9.

    Article  PubMed  CAS  Google Scholar 

  59. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000;95:2937-42.

    PubMed  CAS  Google Scholar 

  60. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002;99:609-17.

    Article  PubMed  CAS  Google Scholar 

  61. van Doorn R, Dijkman R, Vermeer MH, Starink TM, Willemze R, Tensen CP. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma. Cancer Res 2002;62:5389-92.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ACL Laboratories, Great Lakes Pathology, Milwaukee, WI, USA

    Pranil Chandra

  2. Department of Pathology, Clinica Alemana, Santiago, Chile

    Mauricio P. Oyarzo

  3. Department of Hematopathology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Dan Jones

Authors
  1. Pranil Chandra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauricio P. Oyarzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pranil Chandra .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, The University of Texas, Holcombe Blvd. 1515 , Houston, 77030, U.S.A.

    Dan Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Chandra, P., Oyarzo, M.P., Jones, D. (2010). Cutaneous T-cell Lymphomas. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-384-8_24

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-383-1

  • Online ISBN: 978-1-60761-384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation